Eledon Pharmaceuticals, Inc. (ELDN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -22.61M | -14.09M | -14.48M | -17.71M | -16.06M | -18.99M | -11.77M | -7.77M | -8.74M | -9.13M | -12.25M | -8.22M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -40.8% | 25.79% | -23.01% | -127.85% | -83.73% | -107.94% | 3.93% | 5.44% | 11.92% | 3.68% | -168.02% | -32.23% |
| Net Income | -39.02M | -10.45M | -17.46M | -11.22M | -6.5M | -44.62M | 63.63M | -44.91M | -10.29M | -9.63M | -10.35M | -9.58M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 88K | 79K | 97K | 95K | 94K | 94K | 94K |
| Stock-Based Compensation | 0 | 2.46M | 2.43M | 2.69M | 2.86M | 6.58M | 1.78M | 3.06M | 1.69M | 1.71M | 1.73M | 1.72M |
| Deferred Taxes | 0 | 5K | 0 | 0 | 0 | 431K | 0 | 0 | 0 | -889K | 1.25M | 1.62M |
| Other Non-Cash Items | 20.79M | -10.77M | -2.27M | -12.65M | -10.68M | 20.05M | -84.07M | 30.81M | -500K | 265K | -1.73M | -1.72M |
| Working Capital Changes | -4.37M | 4.66M | 2.82M | 3.46M | -1.75M | -1.52M | 6.8M | 3.16M | 265K | -685K | -3.25M | -359K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -4.3M | 4.04M | 566K | 4.52M | -2.4M | -1.04M | 6.55M | 1.79M | 451K | 1.01M | -2.01M | -585K |
| Cash from Investing | 5.96M | -20.46M | 12.4M | 14.96M | 3.89M | -47.38M | -12.8M | -19.91M | 9.78M | 10.08M | -25.03M | -30.33M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.03K | -30.33K |
| Cash from Financing | 0 | 53.69M | 0 | 0 | 115K | 80.17M | 5.28M | 48.07M | 1K | 0 | 0 | 33.02M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 53.69M | -115K | 0 | 115K | 80.17M | 5.28M | 48.07M | 1K | 0 | 0 | 33.02M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 115K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -16.66M | 19.14M | -2.07M | -2.75M | -12.05M | 13.8M | -19.29M | 20.38M | 1.04M | 945K | -37.28M | -5.54M |
| Free Cash Flow | -22.61M | -14.09M | -14.48M | -17.71M | -16.06M | -18.99M | -11.77M | -7.77M | -8.74M | -9.13M | -12.25M | -8.22M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -40.8% | 25.79% | -23.01% | -127.85% | -83.73% | -107.94% | 3.93% | 5.44% | 11.92% | 3.68% | -168.02% | -32.23% |
| FCF per Share | -0.20 | -0.19 | -0.19 | -0.23 | -0.21 | -0.32 | -0.21 | -0.18 | -0.29 | -0.38 | -0.41 | -0.34 |
| FCF Conversion (FCF/Net Income) | 0.58x | 1.35x | 0.83x | 1.58x | 2.47x | 0.43x | -0.15x | 0.17x | 0.37x | 0.95x | 1.24x | 0.13x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |